222 related articles for article (PubMed ID: 20302916)
21. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
[TBL] [Abstract][Full Text] [Related]
22. The functions of UCH-L1 and its relation to neurodegenerative diseases.
Setsuie R; Wada K
Neurochem Int; 2007; 51(2-4):105-11. PubMed ID: 17586089
[TBL] [Abstract][Full Text] [Related]
23. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1.
Tse HS; Hu HY; Sze KH
Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2.
Tirat A; Schilb A; Riou V; Leder L; Gerhartz B; Zimmermann J; Worpenberg S; Eidhoff U; Freuler F; Stettler T; Mayr L; Ottl J; Leuenberger B; Filipuzzi I
Anal Biochem; 2005 Aug; 343(2):244-55. PubMed ID: 15963938
[TBL] [Abstract][Full Text] [Related]
25. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines.
Rolén U; Kobzeva V; Gasparjan N; Ovaa H; Winberg G; Kisseljov F; Masucci MG
Mol Carcinog; 2006 Apr; 45(4):260-9. PubMed ID: 16402389
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.
Bishop P; Rocca D; Henley JM
Biochem J; 2016 Aug; 473(16):2453-62. PubMed ID: 27515257
[TBL] [Abstract][Full Text] [Related]
27. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling.
Bheda A; Yue W; Gullapalli A; Whitehurst C; Liu R; Pagano JS; Shackelford J
PLoS One; 2009 Jun; 4(6):e5955. PubMed ID: 19536331
[TBL] [Abstract][Full Text] [Related]
28. Deubiquitinating enzymes as cellular regulators.
Kim JH; Park KC; Chung SS; Bang O; Chung CH
J Biochem; 2003 Jul; 134(1):9-18. PubMed ID: 12944365
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
30. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
[TBL] [Abstract][Full Text] [Related]
31. Evidence that the Arabidopsis Ubiquitin C-terminal Hydrolases 1 and 2 associate with the 26S proteasome and the TREX-2 complex.
Tian G; Lu Q; Kohalmi SE; Rothstein SJ; Cui Y
Plant Signal Behav; 2012 Nov; 7(11):1415-9. PubMed ID: 22951400
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin C-terminal hydrolase-L3 regulates EMT process and cancer metastasis in prostate cell lines.
Song HM; Lee JE; Kim JH
Biochem Biophys Res Commun; 2014 Sep; 452(3):722-7. PubMed ID: 25194810
[TBL] [Abstract][Full Text] [Related]
33. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.
Hamazaki J; Iemura S; Natsume T; Yashiroda H; Tanaka K; Murata S
EMBO J; 2006 Oct; 25(19):4524-36. PubMed ID: 16990800
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting UCH-L5: Rational Design of a Cyclic Ubiquitin-Based Peptide Inhibitor.
Hameed DS; Ovaa H; van der Heden van Noort GJ; Sapmaz A
Front Mol Biosci; 2022; 9():866467. PubMed ID: 35720124
[TBL] [Abstract][Full Text] [Related]
35. Backbone assignments of the 26 kDa neuron-specific ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1).
Andersson FI; Jackson SE; Hsu ST
Biomol NMR Assign; 2010 Apr; 4(1):41-3. PubMed ID: 20012716
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors.
Mermerian AH; Case A; Stein RL; Cuny GD
Bioorg Med Chem Lett; 2007 Jul; 17(13):3729-32. PubMed ID: 17449248
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel.
Sun J; Shang X; Tian Y; Zhao W; He Y; Chen K; Cheng H; Zhou R
FEBS J; 2008 Jan; 275(2):242-9. PubMed ID: 18076650
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1.
Das C; Hoang QQ; Kreinbring CA; Luchansky SJ; Meray RK; Ray SS; Lansbury PT; Ringe D; Petsko GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4675-80. PubMed ID: 16537382
[TBL] [Abstract][Full Text] [Related]
39. The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.
Randles L; Anchoori RK; Roden RB; Walters KJ
J Biol Chem; 2016 Apr; 291(16):8773-83. PubMed ID: 26907685
[TBL] [Abstract][Full Text] [Related]
40. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
